{
  "DOI": "10.1007/s10689-011-9435-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9435-0",
  "alternative-id": [
    "9435"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kiely",
      "given": "B. E.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "kConFab Investigators",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Friedlander",
      "given": "M. L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Milne",
      "given": "R. L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stanhope",
      "given": "L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Russell",
      "given": "P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jenkins",
      "given": "M. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weideman",
      "given": "P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "McLachlan",
      "given": "S. A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Grant",
      "given": "P.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hopper",
      "given": "J. L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Phillips",
      "given": "K. A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        3,
        21
      ]
    ],
    "date-time": "2011-03-21T05:37:16Z",
    "timestamp": 1300685836000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        9
      ]
    ],
    "date-time": "2019-06-09T06:28:05Z",
    "timestamp": 1560061685000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        6,
        7
      ]
    ],
    "date-time": "2022-06-07T22:27:31Z",
    "timestamp": 1654640851200
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2011,
        3,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2011,
          9
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.springerlink.com/index/pdf/10.1007/s10689-011-9435-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "505-514",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        3,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        3,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9435_CR1",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130 [erratum appears in Am J Hum Genet. 2003 Sep;73(3):709]",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "9435_CR2",
      "unstructured": "Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "issue": "5645",
      "journal-title": "Science",
      "key": "9435_CR3",
      "unstructured": "King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "9435_CR4",
      "unstructured": "Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408",
      "volume": "336",
      "year": "1997"
    },
    {
      "author": "JM Satagopan",
      "first-page": "467",
      "issue": "5",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9435_CR5",
      "unstructured": "Satagopan JM, Offit K, Foulkes W et al (2001) The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 10(5):467–473",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2008.18.1107",
      "author": "K Levanon",
      "doi-asserted-by": "crossref",
      "first-page": "5284",
      "issue": "32",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR6",
      "unstructured": "Levanon K, Crum C, Drapkin R (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26(32):5284–5293",
      "volume": "26",
      "year": "2008"
    },
    {
      "key": "9435_CR7",
      "unstructured": "National Breast and Ovarian Cancer Centre (NBOCC) (2011) Familial Risk Assessment - Breast and Ovarian Cancer (FRA-BOC). http://www.nbocc.org.au/fraboc/"
    },
    {
      "DOI": "10.1001/archinte.155.9.905",
      "author": "RA Kerber",
      "doi-asserted-by": "crossref",
      "first-page": "905",
      "issue": "9",
      "journal-title": "Arch Intern Med",
      "key": "9435_CR8",
      "unstructured": "Kerber RA, Slattery ML (1995) The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med 155(9):905–912",
      "volume": "155",
      "year": "1995"
    },
    {
      "DOI": "10.1200/JCO.20.5.1260",
      "author": "L Scheuer",
      "doi-asserted-by": "crossref",
      "first-page": "1260",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR9",
      "unstructured": "Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. [see comment]. J Clin Oncol 20(5):1260–1268",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJMoa012158",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1616",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "9435_CR10",
      "unstructured": "Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616–1622",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/95.14.1072",
      "author": "JL Rutter",
      "doi-asserted-by": "crossref",
      "first-page": "1072",
      "issue": "14",
      "journal-title": "J Natl Cancer Inst",
      "key": "9435_CR11",
      "unstructured": "Rutter JL, Wacholder S, Chetrit A et al (2003) Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 95(14):1072–1078",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2005.04.5260",
      "author": "JG Guillem",
      "doi-asserted-by": "crossref",
      "first-page": "4642",
      "issue": "28",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR12",
      "unstructured": "Guillem JG, Wood WC, Moley JF et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S1470-2045(06)70585-X",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "issue": "3",
      "journal-title": "Lancet Oncol",
      "key": "9435_CR13",
      "unstructured": "Domchek SM, Friebel TM, Neuhausen SL et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223–229",
      "volume": "7",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "80",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "9435_CR14",
      "unstructured": "Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80–87",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ygyno.2004.02.013",
      "author": "B Rosen",
      "doi-asserted-by": "crossref",
      "first-page": "280",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR15",
      "unstructured": "Rosen B, Kwon J, Fung Kee Fung M, Gagliardi A, Chambers A (2004) Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol 93(2):280–286",
      "volume": "93",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2005.04.109",
      "author": "CB Powell",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "issue": "1",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR16",
      "unstructured": "Powell CB, Kenley E, Chen LM et al (2005) Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol 23(1):127–132",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ygyno.2005.05.002",
      "author": "Society of Gynecologic Oncologists",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR17",
      "unstructured": "Society of Gynecologic Oncologists (2005) Clinical practice committee statement on prophylactic salpingo-oophorectomy. Gynecol Oncol 98(2):179–181",
      "volume": "98",
      "year": "2005"
    },
    {
      "DOI": "10.1097/00000478-200110000-00009",
      "author": "TJ Colgan",
      "doi-asserted-by": "crossref",
      "first-page": "1283",
      "issue": "10",
      "journal-title": "Am J Surg Pathol",
      "key": "9435_CR18",
      "unstructured": "Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B (2001) Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol 25(10):1283–1289",
      "volume": "25",
      "year": "2001"
    },
    {
      "DOI": "10.1006/gyno.2000.6071",
      "author": "PJ Paley",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR19",
      "unstructured": "Paley PJ, Swisher EM, Garcia RL et al (2001) Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 80(2):176–180",
      "volume": "80",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ygyno.2003.12.009",
      "author": "BY Karlan",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR20",
      "unstructured": "Karlan BY (2004) Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis. Gynecol Oncol 92(2):519–520",
      "volume": "92",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ygyno.2004.03.016",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "277",
      "issue": "2",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR21",
      "unstructured": "Kauff ND, Barakat RR (2004) Surgical risk-reduction in carriers of BRCA mutations: where do we go from here? Gynecol Oncol 93(2):277–279",
      "volume": "93",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.ygyno.2006.01.006",
      "author": "JA Villella",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR22",
      "unstructured": "Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K (2006) Role of prophylactic hysterectomy in patients at high risk for hereditary cancers. Gynecol Oncol 102(3):475–479",
      "volume": "102",
      "year": "2006"
    },
    {
      "DOI": "10.1006/gyno.2002.6638",
      "author": "TJ Colgan",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR23",
      "unstructured": "Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B (2002) Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy. Gynecol Oncol 85(3):397–403",
      "volume": "85",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2000.18.14.2728",
      "author": "KH Lu",
      "doi-asserted-by": "crossref",
      "first-page": "2728",
      "issue": "14",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR24",
      "unstructured": "Lu KH, Garber JE, Cramer DW et al (2000) Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 18(14):2728–2732",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2007.12.2622",
      "author": "MJ Callahan",
      "doi-asserted-by": "crossref",
      "first-page": "3985",
      "issue": "25",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR25",
      "unstructured": "Callahan MJ, Crum CP, Medeiros F et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985–3990",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6601692",
      "author": "RI Olivier",
      "doi-asserted-by": "crossref",
      "first-page": "1492",
      "issue": "8",
      "journal-title": "Br J Cancer",
      "key": "9435_CR26",
      "unstructured": "Olivier RI, van Beurden M, Lubsen MA et al (2004) Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. Br J Cancer 90(8):1492–1497",
      "volume": "90",
      "year": "2004"
    },
    {
      "DOI": "10.1006/gyno.2002.6779",
      "author": "K Leeper",
      "doi-asserted-by": "crossref",
      "first-page": "52",
      "issue": "1",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR27",
      "unstructured": "Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 87(1):52–56",
      "volume": "87",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2000.18.9.1980",
      "author": "A Eisen",
      "doi-asserted-by": "crossref",
      "first-page": "1980",
      "issue": "9",
      "journal-title": "J Clin Oncol",
      "key": "9435_CR28",
      "unstructured": "Eisen A, Rebbeck TR, Wood WC, Weber BL (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18(9):1980–1995",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.ygyno.2005.06.065",
      "author": "A Finch",
      "doi-asserted-by": "crossref",
      "first-page": "58",
      "issue": "1",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR29",
      "unstructured": "Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 100(1):58–64",
      "volume": "100",
      "year": "2006"
    },
    {
      "DOI": "10.1097/01.pas.0000202161.80739.ac",
      "author": "ML Carcangiu",
      "doi-asserted-by": "crossref",
      "first-page": "1222",
      "issue": "10",
      "journal-title": "Am J Surg Pathol",
      "key": "9435_CR30",
      "unstructured": "Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S (2006) Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol 30(10):1222–1230",
      "volume": "30",
      "year": "2006"
    },
    {
      "key": "9435_CR31",
      "unstructured": "Rhiem K, Foth D, Wappenschmidt B et al (2010) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Arch Gynecol Obstet. 2010/04/30"
    },
    {
      "key": "9435_CR32",
      "unstructured": "Kathleen Cunningham Consortium for Research into Familial Breast Cancer: kConFab. http://www.kconfab.org"
    },
    {
      "DOI": "10.1186/bcr1377",
      "author": "GJ Mann",
      "doi-asserted-by": "crossref",
      "first-page": "R12",
      "issue": "1",
      "journal-title": "Breast Cancer Res",
      "key": "9435_CR33",
      "unstructured": "Mann GJ, Thorne H, Balleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10689-004-6129-x",
      "author": "KA Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "9435_CR34",
      "unstructured": "Phillips KA, Butow PN, Stewart AE et al (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105–113",
      "volume": "4",
      "year": "2005"
    },
    {
      "key": "9435_CR35",
      "unstructured": "Australian Society of Gynaecologic Oncologists. http://www.asgo.net.au"
    },
    {
      "key": "9435_CR36",
      "unstructured": "StataCorp (2007) Stata statistical software. College Station, Texas, USA"
    },
    {
      "DOI": "10.1007/s10549-010-0799-x",
      "doi-asserted-by": "crossref",
      "key": "9435_CR37",
      "unstructured": "Domchek SM, Friebel TM, Garber JE et al (2010) Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Res Treat"
    },
    {
      "DOI": "10.1016/j.ajog.2006.03.006",
      "author": "JD Lamb",
      "doi-asserted-by": "crossref",
      "first-page": "1702",
      "issue": "6",
      "journal-title": "Am J Obstet Gynecol",
      "key": "9435_CR38",
      "unstructured": "Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM (2006) Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol 194(6):1702–1709",
      "volume": "194",
      "year": "2006"
    },
    {
      "DOI": "10.1056/NEJMoa020119",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "1609",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "9435_CR39",
      "unstructured": "Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1111/IGC.0b013e3181a1b5dc",
      "author": "JE Hirst",
      "doi-asserted-by": "crossref",
      "first-page": "826",
      "issue": "5",
      "journal-title": "Int J Gynecol Cancer",
      "key": "9435_CR40",
      "unstructured": "Hirst JE, Gard GB, McIllroy K, Nevell D, Field M (2009) High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. Int J Gynecol Cancer 19(5):826–829",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.3121/cmr.2007.702",
      "author": "CP Crum",
      "doi-asserted-by": "crossref",
      "first-page": "35",
      "issue": "1",
      "journal-title": "Clin Med Res",
      "key": "9435_CR41",
      "unstructured": "Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5(1):35–44",
      "volume": "5",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ygyno.2009.01.013",
      "author": "AK Folkins",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "9435_CR42",
      "unstructured": "Folkins AK, Jarboe EA, Roh MH, Crum CP (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 113(3):391–396",
      "volume": "113",
      "year": "2009"
    }
  ],
  "reference-count": 42,
  "references-count": 42,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9435-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer"
  ],
  "type": "journal-article",
  "volume": "10"
}